VEGFA and breast cancer: Lee et al. (2013) demonstrated that MSC-Exos significantly down-regulated the expression of vascular endothelial growth factor in breast cancer cells, thereby inhibiting angiogenesis both in vitro and in vivo. Lin et al. (2013), on the other hand, suggested that MSC-Exos could promote breast cancer cell migration via the Wnt signaling pathway.